Global Pharmaceutical intermediates Market to reach USD XX billion by 2027Global Pharmaceutical intermediates Market is valued approximately at USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2021-2027. Pharmaceutical intermediates are drugs used as raw materials in the production of bulk drugs. Intermediates can be defined as semi-finished products that are later made into the final products. The Pharmaceutical intermediates market is being driven by increasing cases of chronic diseases, growing demand for pharmaceutical-based medicines in CVD cases, and increased cases of infectious diseases. Moreover, according to World health organization (WHO), the population ageing above 60 years will be around 2 billion by 2050, which will give rise to various chronic diseases therefore the market is expected to boost. For instance, according to revised National Tuberculosis Control Program Report, in 2018, around 4.4 lakh patients died due to tuberculosis in India, that is 29% of the total 1.5 million deaths caused by the disease across the world. Thus, such high prevalence of chronic diseases and infectious diseases is increasing the demand for drugs, eventually showcasing the need of pharmaceutical intermediates. However, uneven prices and strict regulation due to enormous small and medium class manufacturers may impede market growth over the forecast period of 2021-2027.

The regional analysis of the pharmaceutical intermediates Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia Pacific has emerged as a significant region across the world in terms of market share due to growing population in the region. Whereas North America is also anticipated to exhibit the highest CAGR over the forecast period 2021-2027, due to the increasing cases of CVD and chronic diseases in the region
Major market player included in this report are:

Chiracon GmbH
BASF SE
Lonza Group
Evonik Industries AG
Cambrex Corporation
DSM
Aceto
Albemarle Corporation
Vertellus
Chemcon Speciality Chemicals Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
GMP
Non-GMP
By Application:
Antibiotics
Antipyretic Analgesics
Vitamins
Others
By Distribution Channel:
Distributor
Direct Sales
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.

Target Audience of the Pharmaceutical intermediates (PSF) Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors